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ABSTRACT 
It has been suggested that patients with bronchiectasis might have increased central 
microtubular orientation angle (CMOA), which leads to poor coordination of ciliary beating, 
and consequently impairment of airway defence. We have employed transmission electron 
microscopy to assess CMOA of ciliated nasal mucosa in a cohort of 133 (81F, 56.8±16.1 year) 
stable bronchiectasis and 59 healthy subjects (30F, 49.3±22.1 year). There was no significant 
difference in CMOA between bronchiectasis (13.2 degree) and control subjects (13.0 degree, 
p=0.82). There was no significant difference in CMOA among patients according to the 
etiology of bronchiectasis, presence of nasal symptoms, or sputum status of Pseudomonas 
aeruginosa infection. Patients with more severe bronchiectasis, i.e. those with FEV1 <60%, 
FVC <60%, or more than 4 bronchiectatic lung lobes, had significantly lower CMOA than their 
counterparts (p<0.05). There was no correlation between CMOA with age, 24h sputum volume, 
exacerbation frequency, FEV1, FVC, or the number of bronchiectatic lung lobes (p>0.05). CMOA 
correlated with ciliary beat frequency (negative), and the percent of cilia showing ultrastructural 
or microtubular defects (p<0.05). Central microtubular orientation angle does not correlate with 
clinically important parameters, in contrary to the results reported by previously published 
smaller scale studies. 
 
KEY WORDS 
Bronchiectasis, cilia, transmission electronic microscopy, ciliary central microtubular 
orientation   
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INTRODUCTION  
Cilia are minute hair-like structures present on the surface of mucosal cells in the airways that 
beat continuously to maintain the sterility of the lower respiratory tract in health. The 
structure of cilia, which consists of the classical “9+2” microtubular arrangement, is highly 
conserved at different levels of the airways and across all species (Figure 1). Ciliary 
dysfunction results in reduced mucosal transport mechanisms leading to chronic retention of 
secretions and impairment of mucosal function, as manifested by patients with primary ciliary 
dyskinesia (PCD), a hereditary condition whereby ciliary beat is dyskinetic (1). Patients suffer 
from chronic upper and lower airway sepsis, and occasionally male sterility and situs inversus 
typical of Kartagener’s syndrome (1). Ciliary motility abnormalities, such as immotility and 
dyskinesia have long been established on PCD patients, and appear to be etiologically related to 
the underlying ultrastructural ciliary defects.  
 
Many ultrastructural ciliary defects have been described and these include deficiency of dynein 
arms, nexin links, radial spokes, central sheath, inner microtubules, and even the entire axoneme 
(2-9). In order for neighboring cilia to beat in a co-ordinated fashion, their central 
microtubules must orientate in a parallel fashion. Such coordination of ciliary beating could 
be assessed by measuring the standard deviation of the angles formed between the central 
microtubules of neighboring cilia with the x-axis (Figure 2). This standard deviation is known 
as the central microtubular orientation angle (CMOA) (10-12). While ultrastructural defects 
of cilia, such as absence of dynein arms and microtubular abnormalities, have been reported 
as etiologically important in bronchiectasis, probably limited by technical requirements, 
studies on CMOA are scare. It has been proposed that disorientation of ciliary central 
microtubules alone could lead to the development of bronchiectasis (10), as a few such 
patients have been reported to develop otherwise idiopathic bronchiectasis, despite normal 
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ciliary beating and ultrastructure. Indeed, central microtubular disorientation, when the 
neigboring cilia do not beat in the same directions, has even been proposed to be a new 
variant of PCD (10).  
 
However, there has not been any systematic evaluation of the clinical significance of central 
microtubular orientation in bronchiectasis. We have, therefore, performed this prospective 
study to determine the correlation of CMOA with disease severity (FEV1, FVC and number 
of bronchiectatic lung lobes) and activity (24h sputum volume and exacerbation frequency) 
markers, and sputum infection status on a cohort of 133 stable bronchiectasis patients. We 
have also determined the relationship between CMOA with ciliary function (as beat 
frequency) and ultrastructure in the same cohort, which also contained 6 patients with 
Kartagener’s syndrome (dextrocardia, sinusitis and bronchiectasis), a variant of PCD.  
 
METHODS  
Non-smoking healthy subjects, who have no respiratory or nasal symptoms for at least 2 weeks 
and no known systemic diseases, were recruited as controls with written informed consent. 
Patients with HRCT-proven bronchiectasis, who are stable in spirometry, sputum production 
and symptoms for at least 3 weeks, were recruited with written informed consent (13). 
Exclusion criteria included presence of rhinosinusal disease other than rhinosinusitis, previous 
nasal surgery or radiotherapy, asthma, and other known respiratory diseases. The protocol was 
approved by the institutional ethics committee. 
 
For each patient, the number of bronchiectatic lung lobes was determined from a thoracic 
HRCT, performed within 12 months (14). The number of exacerbations occurring in the 
preceding 12 months, was determined by history taking and review of clinical charts (13). Lung 
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function indices were measured with a SensorMedics 2200 (SensorMedics, Yorba Linda, USA) 
package. The etiology of bronchiectasis was determined as described previously (15). The 
volume of 24h sputum was determined as the mean of a three consecutive day collection (13). 
Post-physiotherapy sputum was collected for microbiological examination, using enriched 
and selective agar plates, to identify all the sputum bacteria (16).  
 
Suspensions of nasal epithelium in Medium 199 (Flow Laboratory, New York, USA) was 
obtained without anesthesia from the inferior turbinate of subjects with a cytology brush 
(1,11,17), and assessed for ciliary beat movements and frequency with an established 
photometric technique. Very briefly, the frequency that the beating cilia, examined at 100x and 
10 different sites, interrupted a light source was determined as ciliary beat frequency (Hz) 
(1,11,17). A 70-90nm section through the central portion of each specimen was taken for 
transmission electron microscopy (TEM) examination at 10,000-22,000x (1,11,17). 
Microtubular assessment included evaluation of presence of single microtubules, extra central 
pair of microtubules (“9+4”), extra peripheral microtubule, “8+2”, “9+1”, “9+0”, compound 
cilium, dynein arm, or microtubular disarrangement was performed on each of the ciliary 
sections (2-9). The orientation of the ciliary central microtubules was determined as described 
previously (10,11,17). Briefly, a line was drawn electronically through the central pairs of 
microtubules with an image analysis package (Improvision, Cambridge, UK). The SD of the 
angle made by each of these lines to the horizontal axis, drawn to intersect a line linking the 
centres of both central microtubules, was determined (Figure 2). A mean SD was obtained from 
all the epithelial cells for each patient, which represented CMOA (10,11,17,18). By convention, 
only TEM specimens with more than 20 cilia captured in full cross section, obtained from at 
least 6 different epithelial cells, were analysed (10,11,17). 
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Unless otherwise stated, data were expressed as mean, standard deviation (SD), and range. 
Pearson’s or Spearman rank correlation analyse was performed to examine the relationship 
between continuous clinical parameters, CMOA, and ciliary beat frequency. Such correlation 
analysis was not performed for the Kartagener’s patients as there were only 6 cases. Categorical 
data were compared using t-test or non-parametric tests when appropriate. A p value of < 0.05 
was considered to indicate statistical significance. The analysis was performed using the 
SPSS® 10.0 Version package (SPSS Inc., Chicago, IL, USA). 
 
RESULTS 
Subject demography and clinical characteristics 
133 bronchiectasis patients (81F) were recruited between June 1997 and May 2001. The mean 
(± S.D.) age for the subjects was 56.8 ± 16.1 (range 12-82) years. The spirometry data, 24h 
sputum volume, number of bronchiectatic lobes, exacerbation frequency, etiology of 
bronchiectasis and sputum bacterial pathogen data, and medications are shown in Table 1. 
There were 6 patients with Kartagener’s syndrome (3F, 28.5 ± 8.9 yrs), who were significantly 
younger than their control counterparts (p=0.02). There were altogether 59 (30F, 49.3 ± 22.1 
yrs) healthy control subjects who donated respiratory cilia for this study. 
 
Light microscopy assessment 
Light microscopy assessment of the ciliary specimens was performed on the entire cohort of 
133 bronchiectasis and 59 control subjects. The mean ciliary beat frequency for the 
bronchiectatic patients was significantly lower than that of the control subjects (11.3 ± 2.5, 
range 0-15.7; and 13.1 ± 1.6, range 9.6-16.2 Hz respectively; p=0.001). Apart from the patients 
with Kartagener’s syndrome, none of the patients or control subjects showed evidence of ciliary 
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dyskinesia or immotility on light microscopy examination. Among the patients with 
Kartagener’s syndrome, ciliary beat frequency (3.9 ± 6.1 Hz) was significantly lower than that 
of their bronchiectasis counterparts (11.6 ± 1.6 Hz, p<0.001) and control subjects (p<0.001).  
 
Transmission electron microscopy assessment (Table 2) 
All bronchiectatic and control subjects had adequate TEM examination of microtubules, ciliary 
matrix and ciliary tail. Significantly more ciliary sections were examined for bronchiectatic 
(140.6 ± 95.9) than control subjects (106.7 ± 79.4, p=0.02). Significantly more patients with 
bronchiectasis displayed microtubular defects than control subjects (p=0.001). Of these, there 
were significantly more patients displaying microtubular defects, “8+2”, or compound cilia, 
when compared with control subjects (p<0.05). However, there were no significant differences 
between bronchiectasis patients and control subjects in the percent of subjects showing “8½+2”, 
“9+4”, extra peripheral microtubules, “9+1”, “9+0”, absence of outer dynein arm, or 
disarrangement of microtubules (p>0.05). The 6 Kartagener’s patients showed significantly 
more percent of sections showing lack of dynein arm (35.9 ± 24.7%), compared with control (0 
± 0%, p<0.001), and their bronchiectasis counterparts (0.04 ± 0.46%, p<0.001). Patients with 
Kartagener’s syndrome also showed significantly more percent of sections with microtubular or 
any ultrastructural defects than their bronchiectasis counterparts (p<0.001 for both), and control 
subjects (p<0.001 for both). However, there was no significant difference in their percent of 
sections showing any of the aforementioned individual defects (data not shown, p>0.05).  
 
There was no significant difference in CMOA between bronchiectasis patients (13.2 ± 5.1 
degree, range 4.2 – 30.2) and control subjects (13.0 ± 3.6 degree, p=0.82). However, there was a 
significant difference in CMOA between patients from different aetiology subgroups (p=0.02). 
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Patients with Kartagener’s syndrome (18.6 ± 7.3 degree) had a significantly higher CMOA than 
their bronchiectasis (12.9 ± 4.8 degree, p=0.01) and control counterparts (13.0 ± 3.6 degree, 
p=0.002). Patients with nasal symptoms (n=65, 12.8 ± 5.4 degree), i.e. rhinorrhoea or nasal 
obstruction for more than one day or any epistaxis within the previous 3 months, had no 
significant difference in CMOA from control subjects (p=0.79), or their counterparts (13.6 ± 
4.8, p=0.36). Patients with Pseudomonas aeruginosa infection in their sputum (n=24, 13.31 ± 
5.53 degree) did not differ in CMOA from control subjects (p=0.76), or their patient 
counterparts (13.14 ± 4.99, p=0.88). 
 
Relationship between CMOA and clinical parameters (Table 3) 
There was no correlation between CMOA with age of onset, age on presentation, 24h sputum 
volume, exacerbation frequency, FEV1 %, FVC %, and the number of bronchiectatic lung lobes 
(p>0.05). Patients with FEV1 ≤ 60% predicted (n=47, 12.0 ± 4.7 degree) had significantly lower 
CMOA than their bronchiectasis counterparts (14.1 ± 5.3 degree, p=0.03), but not different from 
that of control subjects (p=0.21). Similarly, patients with FVC ≤ 60% predicted (n=30, 11.5 ± 
4.3 degree) also had significantly lower CMOA than their counterparts (13.8 ± 5.3, p=0.03), but 
not different from that of control subjects (p=0.09). Patients with more than 4 or 5 lung lobes 
affected by bronchiectasis (n=15 and 9, 10.7 ± 4.0 and 8.2 ± 2.1 degree respectively) had 
significantly lower CMOA than their counterparts (13.7 ± 5.1 and 13.7 ± 5.0 degree, p=0.03 and 
p=0.001 respectively), as well as control subjects (p=0.04 and <0.001 respectively). There was, 
otherwise, no significant difference in CMOA between subgroups of patients according to their 
etiology of bronchiectasis or sputum pathogens (p>0.05, data not shown). 
 
Relationship between CMOA with ciliary and ultrastructural parameters (Table 3) 
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There was a significant positive correlation between CMOA and the percent of ciliary 
sections showing microtubular or any ultrastructural defects (p<0.05). There was also a 
significant, albeit weak, negative correlation between ciliary beat frequency and the 
orientation angle (p=0.03). There was no significant correlation between CMOA with ciliary 
beat frequency, number of ultrastructural defects, or the percent of ciliary section showing 
ultrastructural or microtubular defects among the control subjects (p>0.05), although there 
was a trend toward a significant correlation between ciliary beat frequency and CMOA (r=-
0.25, p=0.06).  
 
DISCUSSION 
Our data, obtained from the largest prospective cohort of bronchiectasis to date, showed no 
significant difference in CMOA between bronchiectasis patients (n=133) and healthy subjects 
(n=59). Although etiology of bronchiectasis had no relationship to CMOA, Kartagener’s 
syndrome had significantly higher CMOA than their bronchiectasis counterparts and control 
subjects. The presence of nasal symptoms was not associated with a difference in CMOA 
among bronchiectasis patients, despite previous report of increased CMOA among 
bronchiectasis patients with mucopurulent nasal discharge (19). The presence of Ps. 
aeruginosa infection in sputum was not associated with any significant difference in CMOA  
although such infection is associated with poor lung function and copious sputum production 
(16). Patients with more severe bronchiectasis i.e. those with FEV1 or FVC <60% predicted, 
or those with more than 4 to 5 lobes affected by bronchiectasis, had significantly lower 
CMOA than their counterparts (p<0.05). It, therefore, appears that central microtubular 
orientation does not correlate with clinical parameters, except among patients with 
Kartagener’s syndrome or PCD. There were weak, albeit statistically significant, correlations 
between CMOA and ciliary beat frequency (negative), and the percent of cilia showing 
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ultrastructural or microtubular defects. The lack of difference in CMOA between patients with 
and without nasal symptoms strongly suggests that ciliary orientation does not have an 
important role in the development of rhinosinusitis among bronchiectasis patients. It, therefore, 
appears that ciliary disorientation is related to abnormalities of ciliary function (beat) and 
ultrastructure, but has little clinical significance among patients with stable non-PCD 
bronchiectasis. 
 
There have only been a few published studies designed specifically to examine CMOA on 
bronchiectasis patients (10-12,18-21). Data from two of these suggest an increase in CMOA in 
bronchiectasis, particularly in severe cases (12,19), although our data showed no such pattern. It 
could be argued that we only used nasal cilia for examination, and this did not reflect the 
changes in the lower airways. However, not only are ciliary function and ultrastructure 
conserved in all species (22), nasal cilia are also the standard specimens used in ciliary 
assessment (23). Previous studies on ciliary orientation were not only few, but also of small 
sample size, ranging from 1-20 bronchiectasis patients with unclear disease stability. These 
studies, nevertheless, also utilised nasal cilia for examination of CMOA (10,12,18,19). It can 
also be argued that only the central microtubular orientation of the ciliary shafts was 
determined, without those of the ciliary tips or basal bodies of the cilia. However, 
measurements of ciliary deviation at the tip, base, and basal feet have been shown to display 
very little variation along the ciliary shafts (12). In addition, other published reports on the 
evaluation of central microtubular orientation also targeted ciliary shafts for such assessment 
(10,12,18,19). 
 
While current literature suggests that ciliary ultrastructural defects are likely to be primary 
defects (24-27), ciliary central microtubular disorientation has been suggested to reflect 
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clinical deterioration, i.e. a secondary defect arisen from noxious insults to the respiratory 
tract (19). Ciliary central microtubular disorientation, as the only ciliary abnormality, has 
been proposed to be a variant of PCD and the primary aetiological factor in the development 
of bronchiectasis among some patients, as it is their only ciliary abnormality and in the 
presence of otherwise idiopathic bronchiectasis (10,18). Treatment with antibiotics and 
topical corticosteroids was reported to be associated with normalization of CMOA in one 
patient (19). Patients with Young's syndrome (obstructive azoospermia with recurrent 
sinobronchial disease) and PCD were found to have abnormal CMOA (12,21,28). However, 
non-PCD bronchiectasis and some PCD patients have been shown to display normal CMOA 
(12). It is, therefore, possible that CMOA is only valuable in helping to make the diagnosis of 
PCD, rather than of any diagnostic or prognostic value in non-PCD bronchiectasis.  
 
Our data cast doubts on the previously proposed key pathogenic role for ciliary disorientation 
in the development of non-PCD bronchiectasis among otherwise idiopathic patients (8,29). 
Bearing in mind that over 80% of bronchiectasis patients have idiopathic disease (30), and in 
light of our data, it is probable that ciliary disorientation is not of clinical significance on non-
PCD bronchiectasis patients. As our data are cross-sectional in nature, further large scale 
longitudinal follow up studies should help to clarify if CMOA would alter according to 
clinical status, and whether or not patients with abnormal CMOA could revert to normal, thus 
on the primary or secondary nature of ciliary disorientation in PCD. 
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LEGEND TO FIGURES 
Figure 1 Cross sectional view of A). a schematic diagram and B). a transmission 
electron micrograph (20,000x) of a cilium showing the classical “9+2” 
appearance. There are 9 peripheral microtubules and 2 central microtubules, 
which are arranged in an orderly manner. Central microtubules from 
neighboring cilia are normally orientated in the same plane and in parallel. 
Figure 2 A transmission electron micrograph of the cross section of a cilium showing the 
way to determine the angle between the horizontal axis and a line drawn 
between the two central microtubules. Determination of the mean of the standard 
deviations of such angles of neighbouring cilia will yield an index of ciliary 
central microtubular orientation for the patient (20,000x).  
Figure 3 A transmission electron micrograph of the cilia of A). a normal subject showing 
normal orientation of central microtubules of neighbouring cilia and B). patient 
with severe bronchiectasis who had normal ciliary beat frequency and ciliary 
ultrastructure but abnormal orientation of the central microtubules (10,000x).  
Table 1 Details of patients with bronchiectasis who underwent ciliary central microtubular  
  orientation assessment 
  
Parameter     Bronchiectasis (N=133; 81F) 
 
Mean ± SD age (yr)    56.8 ± 16.12 
 
FEV1 (% pred)     
Mean ± SD (inter-quartile range)  73.6 ± 30.45, (45.25,100.50) 
FVC (% pred)  
Mean ± SD (inter-quartile range)  82.2 ± 24.94, (61.00,99.00) 
24h sputum volume (ml)#   10.0 (5.0,25.0) 
Number of bronchiectatic lung lobes#  3 (2,4) 
Exacerbation frequency (per year)#  2 (1,4) 
Aetiology of bronchiectasis    N 
 Idiopathic    104 
 Post-tuberculous   17 
 Post-pneumonic    2 
 Kartagener’s syndrome   6 
 Diffuse panbronchiolitis   3 
 IgG deficiency    1 
  
Sputum bacterial pathogen    
 Commensals    61 
 Haemophilus influenzae   11 
 Streptococcus pneumoniae  8 
 Pseudomonas aeruginosa  24 
  
Medications taken by patients  
 Inhaled bronchodilators   41 
 Inhaled steroids    15 
 Theophylline    4 
 Anti-hypertensives   14 
 Diuretics    4 
 Allopurinol    7 
 Aspirin     4 
 Digoxin    2 
 Thyroxine    1 
 Nil     63 
 
FEV1= forced expiratory volume in one second and FVC = forced vital capacity. 
*Unless otherwise stated, data shown are medians (inter-quartile ranges). 
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Table 2 Ciliary ultrastructural abnormalities detected in bronchiectasis and control subjects 
 
     Numbers of patients (%) showing 
 
     Bronchiectasis  Control  *p 
 Ultrastructural finding  (N=133)  (N=59) 
 
 
 Microtubular defects  105 (80.2%)  32 (54.2%)  <0.001 
 
 Extra peripheral microtubule 76 (58.0%)  25 (42.4%)  0.05 
 
 “9+4”    6 (4.6%)  1 (1.7%)  0.44 
 
 “8+2”    36 (27.5%)  8 (13.6%)  0.04 
 
 “8½+2”   47 (35.9%)  18 (30.5%)  0.47 
 
 “9+1”    11 (8.4%)  1 (1.7%)  0.11 
 
 “9+0”    8 (6.1%)  1 (1.7%)  0.28 
 
 Absence of outer dynein arm 4 (3.1%)  0 (0%)   0.31 
 
 Compound cilium  97 (74%)  25 (42.4%)  <0.001 
 
 Disarrangement of  51 (38.9%)  21 (35.6%)  0.66 
 microtubules 
  
*p value when compared the two subject groups.  
Refer to methodology section for description of ciliary ultrastructural defects. 
 18
Table 3 Relationship between central ciliary microtubular orientation, and demographic and 
clinical parameters of disease severity in patients with steady state bronchiectasis 
 
 
   Central microtubular orientation angle  
 
     Bronchiectasis patients Control  
r (p)    r (p)  
 
Age of onset of disease (yr)  0.04 (0.75)    
 
Age at presentation (yr)  -0.09 (0.32)    
 
24h volume (ml)   -0.08 (0.39)    
 
Exacerbation frequency (per year) 0.14 (0.13)    
 
FEV1 % predicted    0.13 (0.15)    
 
FVC % predicted    0.15 (0.10)    
 
No. of bronchiectatic lung lobes -0.03 (0.72)    
 
Ciliary beat frequency (Hz)  -0.19 (0.03)   -0.25 (0.06) 
 
No. of ultrastructural defects 0.11 (0.21)  0.02 (0.91) 
 
% of cells with   0.19 (0.03)  0.06 (0.63) 
ultrastructural defects  
 
% of cells with   0.26 (0.003)  0.13 (0.31) 
microtubular defects  
  
 
Data shown are Spearman rank correlation coefficients and p values.  
Values with p < 0.05 are in bold. 
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